MoneyWorks4Me

Cadila Healthcare informs about analyst meet

22 May 2021 Evaluate
Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cadila Healthcare has informed that post results Q&A session through teleconference has been scheduled on May 27, 2021 at 4:30 pm. Sharvil Patel, Managing Director of the Company would be hosting the call. The call will be conducted through the audio webcast format.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..